>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • HUBS +20.9%, GP +13.3% (also enters into purchase agreement for up to 150 GreenPower EV Star Cab and Chassis), CGNX +11.3% (also Chairman to resign), TWOU +7.9%, VCRA +6.5%, IMGN +6.4%, JCOM +6%, CUZ +5.1%, ING +5%, VRSN +4.6%, RARE +3.5%, CC +3.3% (also to split Fluoroproducts segment into two new segments), MHK +2.6%, HUN +2.6%, FROG +2.3%, REG +1.5%, DIS +1.5% (Disney+ subs at 94.9 mln), PRLB +1.4%, WPC +1.4%, FTS +1.2%, BIO +1%

Other news:

  • XERS +27.9% (receives EC approval for Ogluo Injection)
  • RTP +11.8% (nearing merger deal with Joby Aviation, according to FT)
  • FTFT +8.3% (enters agreement with China Foundation of Consumer Protection to use blockchain technology against counterfeit products)
  • FUSE +6.5% (Fusion Acquisition Corp: MoneyLion, digital financial platform, to become publicly traded via merger with Fusion Acquisition Corp)
  • CVAC +6.4% (initiates rolling submission with European Medicines Agency for COVID-19 vaccine candidate, CVnCoV)
  • BHC +5.7% (issued statement in response to the Schedule 13D filed by Icahn Capital)
  • TMQ +5.3% (provides approval for JV to enter into an Ambler Access Dev Agreement with AIDEA)
  • DNLI +5% (interim results from the ongoing Phase 1/2 study evaluating ETV:IDS as a potential brain-penetrant enzyme replacement therapy for treating both central nervous system and peripheral manifestations of Hunter syndrome)
  • INFI +4.9% (stock offering)
  • CLPT +4.2% (announces a multi-product development deal with Blackrock Microsystems)
  • FCAC +4.1% (Falcon Capital Acquisition Corp and Sharecare reach agreement to combine, creating publicly traded digital health company)
  • APLT +2.9% (prices offering of 3 mln shares of common stock at $23.00 per share) ST +2.8% (to acquire telematics and data insight provider, Xirgo Technologies Intermediate Holdings for $400 mln)
  • MRNA +1.1% (President Biden confirms that PFE and MRNA will sell 200 mln COVID-19 doses to US; MRNA confirms US has purchased an additional 100 mln doses)

Analyst comments:

  • NWSA +3.7% (upgraded to Overweight from Underweight at Morgan Stanley)
  • YETI +1.9% (upgraded to Buy from Neutral at Citigroup)
  • CPRT +0.9% (upgraded to Overweight from Equal-Weight at Stephens)